IREB2 and breast cancer: To determine whether IRP2 inhibition markedly enhanced radiation sensitivity in BC cells, we initially examined the cytotoxic effects of combined treatment of radiation and KS-20226 in MDA-MB-468 and MDA-MB-453 cells, both of which were categorized in the RI group.